Amarantus Bioscience Holdings Inc (AMBS)

[joboggi]

Furthermore, in all his previous writings JN noted that they would be discriminating AD v Non ad dementia, and not ad v non ad.

The FIRST place that I noted the LESS than 90% sen for ad v non ad in Steiler 2012 was in JN's article. It is 88%. You can find the link to that article in my stickie.

The SENSITIVITY for ad v NON ad has NEVER been higher than 88%.
It was inexplicably higher when they compared AD v PD dementia, but that is not pertinent, since most people in the studies who do not have AD but have dementia will have mixed or vascular dementia, and PD dementia is fairly easy to discern because of the PD symptoms.

JN gets confused so to speak, more to the point, he writes about the current line of the day proferred by GC and company.